Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per mL

국가: 뉴질랜드

언어: 영어

출처: Medsafe (Medicines Safety Authority)

유효 성분:

Glycopyrronium bromide 0.5 mg/mL; Neostigmine metilsulfate 2.5 mg/mL

제공처:

Boucher & Muir (NZ) Ltd t/a Mercury Pharma (NZ)

INN (International Name):

Glycopyrronium bromide 0.5 mg/mL

약제 형태:

Solution for injection

구성:

Active: Glycopyrronium bromide 0.5 mg/mL Neostigmine metilsulfate 2.5 mg/mL Excipient: Citric acid Citric acid monohydrate Dibasic sodium phosphate dodecahydrate Sodium hydroxide Water for injection

처방전 유형:

Prescription

Manufactured by:

PCAS Finland Oy

치료 징후:

Reversal of residual non-depolarising (competitive) neuromuscular block.

제품 요약:

Package - Contents - Shelf Life: Ampoule, glass, Type I - 10 dose units - 24 months from date of manufacture stored at or below 25°C protect from light

승인 날짜:

2012-08-30